Feb 22, 2021 | Uncategorized
VANCOUVER, Wash., – February 22, 2021 – AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, today announced a strategic equity investment by Merck Global Health Innovation Fund (Merck GHI) and potential...
Feb 3, 2021 | Uncategorized
-Second molecule addressed under the collaboration agreement, first to exploit AbSci discovery technologies- VANCOUVER, Wash., February 3, 2021 /PRNewswire/ — AbSci, a pioneering synthetic biology company enabling drug discovery and biomanufacturing of...
